LifeStance Health (US:LFST)2025-05-07 11:13Financial Performance - Q1 2025 revenue reached $333.0 million, an 11% year-over-year increase[10] - Q1 2025 Center Margin was $109.8 million, representing 33.0% of revenue[10] - Q1 2025 Adjusted EBITDA was $34.6 million, or 10.4% of revenue[10] - The company ended Q1 2025 with a cash position of $134.3 million[10] Operational Metrics - Total clinicians reached 7,535, a 10% year-over-year increase, with 152 net clinician additions in Q1[10] - Q1 2025 visit volumes totaled 2.1 million, a 10% year-over-year increase[10] - The company operates over 550 centers in 33 states[8] Future Outlook - The company reaffirmed its FY 2025 revenue guidance of $1.40 billion to $1.44 billion[20] - The company reaffirmed its FY 2025 Adjusted EBITDA guidance of $130 million to $150 million[20] - The company anticipates opening 25 to 30 de novo centers in 2025[23]